Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells.
Shcherbik S, Pearce N, Carney P, Bazhenova E, Larionova N, Kiseleva I, Rudenko L, Kumar A, Goldsmith CS, Dugan V, Stevens J, Wentworth DE, Bousse T.
Shcherbik S, et al. Among authors: rudenko l.
Vaccine X. 2019 Jun 19;2:100031. doi: 10.1016/j.jvacx.2019.100031. eCollection 2019 Aug 9.
Vaccine X. 2019.
PMID: 31384746
Free PMC article.